A Step-by-Step Overview of MHRA Registration for Your Medical Device

Placing your medical device on the Great Britain market (England, Wales, and Scotland) requires understanding the UK medical device regulation process, primarily governed by the Medical Devices Regulations 2002 (as amended). A crucial step in this process is registering your device with the MHRA (Medicines and Healthcare Products Regulatory Agency) before it can be legally sold. 

While the UK medical device regulations 2002 have evolved following Brexit, understanding the MHRA device registration process is critical for market access. This resource provides a step-by-step overview to help manufacturers manage this essential requirement, keeping in mind the upcoming changes to regulations for medical devices in the UK.

The MHRA (Medicines and Healthcare Products Regulatory Agency) is the UK’s governing body for all regulations for medical devices. As the competent authority, the MHRA ensures the safety and performance of UK medical devices on the market.

Key functions of the MHRA include:

• Market Surveillance: Continuously monitors device safety and performance.
• Approved Bodies: Designates and oversees organisations for UKCA marking medical devices conformity assessment.
• Enforcement: Investigates non-compliance and takes action, including market removal.
• MHRA Device Registration: The MHRA manages the mandatory registration of all medical devices before GB market access via the Device Online Registration System (DORS).

MHRA device registration is a fundamental legal requirement for placing any medical device on the Great Britain market. Without it, lawful sale and supply are prohibited. This process ensures the MHRA has a comprehensive database for effective market surveillance and rapid response to safety concerns, ultimately protecting public health under the UK medical device regulation.

Accurately classifying your medical device is the first and most critical step in the MHRA device registration process. This classification dictates your conformity assessment route, required documentation, and post-market obligations.

The UK Medical Device Regulation (UK MDR 2002) categorises devices by risk:

General Medical Devices:

• Class I: Low risk (e.g., bandages). Subcategories include Class Is (sterile) and Class Im (measuring).
• Class IIa: Low to medium risk (e.g., hearing aids).
• Class IIb: Medium to high risk (e.g., infusion pumps).
• Class III: High risk (e.g., pacemakers).
• In Vitro Diagnostic Devices (IVDs): Classified separately (Part IV, UK MDR 2002), aligning with EU IVDD, into General, Self-testing, and risk-based lists (Annex II List A and B).
• Custom-made Devices: Unique category with specific requirements.

Your device’s class determines the regulatory pathway, including self-certification or mandatory UK-Approved Body involvement. Incorrect classification can lead to significant compliance issues.

Classification is risk-based, determined by the device’s intended purpose and associated hazards, as per Part II, Regulation 7 and Annex IX of the EU MDD (modified by Schedule 2A, UK MDR 2002). Key criteria include:

• Duration of Use: Transient (<60 min), Short-term (≤30 days), Long-term (>30 days).
• Invasiveness: Non-invasive, Invasive, Surgically Invasive, Implantable.
• Energy Source: Active or Non-active.
• Interaction with the Human Body: Administration/removal of substances, modification of body fluids, contact with central nervous/circulatory systems.
• Presence of Medicinal/Animal/Human Substances: Incorporation of medicinal substances or use of animal/human tissues.
• IVD classification (Part IV, UK MDR 2002; Annex II, EU IVDD) is based on intended use and risk of erroneous results to individual/public health.

Classification can be complex, especially for borderline products. Consult MHRA guidance or schedule a free call with Russell Regulatory Consultants for expert regulatory advice to avoid misclassification.

Device classification directly impacts every step of the regulatory process for MHRA device registration:

• Conformity Assessment Route: Self-certification for low-risk Class I (non-sterile, non-measuring) and low-risk IVDs. UK-Approved Body required for all other classes for UKCA marking medical devices.
• Technical Documentation: Depth and detail increase with risk class (e.g., Design Dossier for Class III).
• Post-Market Surveillance (PMS): Obligations (report types, frequency) are risk-based.
• Clinical Evidence: Stringency scales with risk (extensive data for Class III).
• Registration Fees and Overall Costs: Higher risk classes incur greater costs due to mandatory UK-Approved Body involvement and more extensive requirements.

Once your medical device is classified, you must undergo conformity assessment to prove it meets the UK medical device regulation (UK MDR 2002) safety and performance requirements. A successful assessment allows you to affix the UKCA marking to medical devices, a prerequisite for the GB market.

Conformity assessment systematically verifies device compliance with the UK MDR 2002’s Essential Requirements (ERs). The specific route depends on your device’s risk class, as detailed in the UK MDR 2002 (often referencing EU Directive Annexes modified for the UK). These routes include various quality assurance systems and examinations.

Class I (non-sterile, non-measuring) general medical devices and low-risk IVDs can typically self-certify. This involves:

• Compiling technical documentation proving ER compliance.
• Creating a formal Declaration of Conformity.
• Affixing the UKCA marking medical devices.

While no UK-Approved Body is initially involved, manufacturers must adhere to all UK medical device regulations and keep documentation available for MHRA inspection.

All other general medical devices (Class Is, Im, IIa, IIb, III) and higher-risk IVDs require assessment by a UK-Approved Body, designated and monitored by the MHRA. You can find a list on the UKMCAB database. The UK-Approved Body typically:

• Audits the manufacturer’s Quality Management System (QMS) (e.g., against ISO 13485 for medical devices).
• Reviews technical documentation (or Design Dossier for Class III) to verify ER conformity.

If satisfied, the UK-Approved Body issues a UKCA certificate of conformity, allowing you to create your Declaration of Conformity and affix the UKCA marking for medical devices alongside the UK-Approved Body’s identification number.

The UKCA marking for medical devices signifies compliance with applicable UK law. To affix it, you must:

• Correctly classify your device.
• Ensure it meets all relevant Essential Requirements.
• Undergo the correct conformity assessment (self or UK-Approved Body).
• Create a UK Declaration of Conformity.
• Compile technical documentation.
• Affix the UKCA marking visibly with the UK-Approved Body’s number if involved.

Great Britain continues to accept CE marking medical devices for a limited time with varying deadlines based on device type, class, and the EU legislation it complies with.

Crucially, even with CE marking under transition, you must register your device with the MHRA. Specific rules apply for registering devices with expiring CE marking under EU MDR/IVDR transitional provisions.

Transitioning to full UKCA marking medical devices is the long-term strategy for sustained GB market access.

Northern Ireland follows EU regulations for medical devices, generally requiring CE marking for medical devices. If a UK-Approved Body is used for mandatory third-party assessment for NI, the CE marking must be accompanied by the UKNI mark. Devices with only the UKNI mark cannot be placed on the EU/EEA market.

For manufacturers based outside the UK, appointing a UK Responsible Person (UKRP) is mandatory for placing medical devices on the Great Britain market. The UKRP acts as your formal UK representative in the regulatory process.   

A UKRP is required if you (the manufacturer) are not established in the UK and want to sell your devices in Great Britain. This includes manufacturers in the EU and other countries. The UKRP must have a registered UK business address. The MHRA will only accept device registration via DORS from UK-based manufacturers or their appointed UKRP.   

Check our guide on Understanding the Role and Responsibilities of the UK Responsible Person for more detailed information.

Compiling and maintaining thorough technical documentation is fundamental to demonstrating your medical device meets UK medical device regulations. This evidence supports your claims of safety, quality, and performance.

Your technical documentation must clearly and unambiguously demonstrate compliance. Key elements generally include:

• Device Description and Specification: Comprehensive overview of the device, its intended use, operation, classification, materials, and technical details.
• Information Supplied by the Manufacturer: Copies of all labels, packaging, and Instructions for Use (IFU).
• Design and Manufacturing Information: Details on design stages, drawings, material specifications, manufacturing processes, sterilisation methods (if applicable), and quality controls.
• GSPR/ER Checklist: Demonstrating how your device meets each applicable Essential Requirement of the UK medical device regulation, often referencing relevant designated standards.
• Benefit-Risk Analysis and Risk Management File: Comprehensive file (typically to ISO 14971) documenting hazard identification, risk evaluation and control, and residual risk acceptability.
• Product Verification and Validation Data: Evidence that the device performs as intended and meets specifications, including test results, pre-clinical evaluations, and clinical evidence.
• Post-Market Surveillance (PMS) Plan and Reports: Your PMS plan and subsequent reports.
• Declaration of Conformity (DoC): A signed copy of your UK DoC.

Remember, technical documentation is a “living file” requiring continuous updates throughout the device lifecycle to reflect any changes or new data.

Documentation and UK-Approved Body scrutiny do vary by risk class:

• Class I: Technical File held by you/your UKRP, available for MHRA inspection.
• Class IIa/IIb: More extensive Technical File reviewed by a UK-Approved Body.
• Class III: Comprehensive Design Dossier with in-depth design examination by a UK-Approved Body.

The MHRA can request further documentation for any class.

The UK DoC is the legally binding statement that your medical device meets UK medical device regulation requirements. It’s needed before UKCA marking and MHRA device registration. It includes manufacturer/UKRP details, device identification, risk class, applicable regulations, referenced standards, UK-Approved Body details (if applicable), place/date of issue, and authorised signature. A copy is part of your technical documentation and is typically uploaded to DORS.

Compliant labelling and IFU are crucial for safe device use and must meet the UK medical device regulation Essential Requirements. Labelling must include manufacturer/UKRP details, device identification, and any specific safety information (e.g., sterility, single-use, warnings). The IFU provides detailed usage instructions, and all labelling and IFU for the GB market must be in English.

After successful conformity assessment and UKRP appointment (if needed), the final mandatory step is to register your medical device with the MHRA via the Device Online Registration System (DORS).

DORS is the MHRA’s online portal for registering all medical devices for the Great Britain market. UK-based manufacturers and UKRPs for non-UK manufacturers must use DORS before placing devices on the market. DORS also manages registration updates and Certificates of Free Sale.

Create an account on the MHRA Agency portal (refer to the Device Registrations Reference Guide). Key obligations include:

• Accuracy: Ensure all information is accurate and current.
• Legal Manufacturer: Register under the legal manufacturer.
• UKRP Formalities: UKRPs must upload a valid Letter of Designation (max 5-year validity).
• Compliance Declaration: Declare compliance with relevant UK regulations.
• Importer Management: UK entities must add importer details.

MHRA device registration is just the beginning. Continuous Post-Market Surveillance (PMS) and vigilance are legally mandated to ensure the ongoing safety and performance of your medical devices in real-world use.

Manufacturers must establish and maintain a proactive PMS system to collect, record, and analyse device performance data throughout its lifecycle. Objectives include identifying new risks, confirming benefit-risk, detecting problems, and updating technical documentation. Vigilance, the reporting of serious adverse incidents and field safety corrective actions (FSCAs) to the MHRA, is a key part of PMS.

Effective 16th June, 2025, new UK medical devices regulations (PMS SI 2024 No. 1368) significantly enhance PMS in Great Britain. Key changes demand proactive, data-driven monitoring and include:

• Mandatory PMS Plans.
• Faster Serious Incident Reporting.
• Clearer CAPA Communication.
• Extended Record Keeping (10-15 years).
• Consideration of User Feedback.

Enhanced PMS within your QMS is now crucial for UK market access.

You (or your UKRP) must report specific adverse incidents to the MHRA electronically via MORE, including device malfunctions, inadequate information, and undesirable side effects leading to serious health consequences. Reporting timelines are becoming stricter under the new medical device regulations. Trend reports for statistically significant increases in non-serious incidents and Periodic Summary Reports (PSRs) may also be required.

To ensure a more efficient MHRA device registration process, all manufacturers should consider these recommendations. For those with limited in-house regulatory expertise or those new to the UK market, partnering with experienced regulatory consultants can be particularly beneficial.

• Plan Early and Integrate Regulatory Strategy: Regulatory planning must be a core element of your medical device product development lifecycle from the outset.
• Invest in Regulatory Expertise: Accessing up-to-date regulatory knowledge and strategic advice is crucial. While building in-house capabilities is valuable, engaging experienced regulatory affairs consultants, like Russell Regulatory Consultants, can provide immediate access to specialised expertise in UK medical device regulation. Consultants offer invaluable guidance on the MHRA device registration process, understanding regulation changes for medical devices, and developing effective compliance strategies.
• Maintain a Robust Quality Management System (QMS): A well-implemented QMS, compliant with ISO 13485 for medical devices, is fundamental. Regulatory consultants can assist in establishing, auditing, and maintaining a QMS that meets MHRA expectations and ensures successful conformity assessment by UK-Approved Bodies.
• Engage with UK-Approved Bodies Early: For devices requiring UK-Approved Body certification, early engagement is vital. Consultants can manage communication and help you understand specific requirements and timelines.
• Thorough and Meticulous Document Preparation: Complete, accurate, and well-organised technical documentation is essential for a smooth MHRA device registration. Regulatory services from experts ensure technical files that meet UK medical device regulations and are audit-ready.
• Proactive and Comprehensive PMS Planning: Implementing a robust Post-Market Surveillance (PMS) system is critical for ongoing compliance. Consultants can provide guidance on establishing effective PMS plans and reporting procedures.

Successfully managing the MHRA device registration process is vital for accessing the lucrative UK market with your medical device. While the regulations for medical devices in the UK can seem daunting, a clear, step-by-step approach, coupled with strategic planning, lays the groundwork for a compliant and timely entry.

At Russell Regulatory Consultants, we take on the UK medical device regulation process for you, providing you with a clear, actionable strategy for MHRA device registration. From understanding device classification and UKCA marking to the changes to UK medical device regulations, we’re here to guide you.

Imagine confidently placing your medical device on the UK market, secure in the knowledge that you’ve tackled every regulatory hurdle with precision and expertise. Envision a partnership that simplifies the MHRA device registration and ensures your long-term compliance with evolving regulations for medical devices.

Don’t let the complexities of MHRA device registration delay your UK market entry. Schedule a free call with Russell Regulatory Consultants today. Let our experts chart a personalised course for your success, transforming regulatory hurdles into stepping stones to your UK market triumph.

1. MHRA. Products.Accessed 13th May 2025.
2. MHRA. Device Online Registration System (DORS). Accessed 13th May 2025.
3. gov.uk. “Consultation on the future regulation of medical devices in the United Kingdom: Chapter 2 — Classification.” Accessed 13th May 2025.  
4. legislation.gov.uk. UK Medical Devices Regulations 2002 — Part II. Accessed 13th May 2025.
5. legislation.gov.uk. UK Medical Devices Regulations 2002 — Contents. Accessed 13th May 2025.
6. gov.uk. Find a conformity assessment body. Accessed 13th May 2025.
7. European Commission. Medical Devices. Accessed 13th May 2025.
8. ISO. ISO 13485:2016. Accessed 13th May 2025.
9. gov.uk. UKCA marking: conformity assessment and documentation. Accessed 13th May 2025.
10. MHRA. How to Register. Accessed 13th May 2025.
11. gov.uk. Effective field safety notices (FSNs): guidance for manufacturers of medical devices. Accessed 13th May 2025.